Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO

2 years ago

Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a…

Tinley’s Brings Three New Clients to Its Long Beach Facility, Announces Debt Settlement and Provides Corporate Update

2 years ago

Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - June 27, 2022) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX:…

PicnicHealth Closes $60 Million Series C Financing to Deliver New Solutions for Patient-Centered Real-World Data and Evidence Generation

2 years ago

Company plans to add 30 new disease cohorts to its PicnicHealth Research Platform SAN FRANCISCO--(BUSINESS WIRE)--#RWD--PicnicHealth, a patient-centered health technology…

Valtruis Brings Advanced Healthcare Data Analytics Capabilities Into Its Portfolio With Ursa Health Partnership

2 years ago

NEW YORK--(BUSINESS WIRE)--#valuebasedcare--Valtruis, a WCAS company, has entered a strategic partnership with Ursa Health, a healthcare data analytics company that…

Defence Reports Effective Control of Cervical Cancer Growth in Response to Its AccuVAC-PT007 Therapeutic Vaccination

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

Prof. Dr. Raimar Loebenberg Receives Leadership Award from the Canadian Society for Pharmaceutical Sciences

2 years ago

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / June 27, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT)…

Poolbeg Pharma PLC Announces Project update for AI model of RSV data

2 years ago

OneThree Biotech completes build and optimisation of AI model for RSV data - results to come in H2First time AI…

Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

2 years ago

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEPCTCs, CTC clusters and CTC-WBC clusters harvested using Parsortix…

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

2 years ago

Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against…